Michael Kolodziej, MD, suggests that payer concerns about the overall structure of the Oncology Care Model caused CMS to delay its letter of intent deadline. In this segment, the managed care stakeholders discuss why payers may be hesitant to apply for enrollment into the program.
Together, Dr Kolodziej; Brian Kiss, MD; and Ted Okon, MBA, comment that the model has great potential to transform the overall delivery of patient care but is far too prescriptive. Mr Okon remarks that the CMS is attempting to “dictate medicine.” However, he adds that despite these far-reaching recommendations, some practices are simply refusing to change their processes.
A variety of performance-based measures need to be evaluated under the Oncology Care Model, notes Dr Kolodziej. Despite reporting on all these different measures, he suggests that there are additional concerns about whether or not a physician will be reimbursed.
Dr Kolodziej also remarks that the model is structured to eliminate practices that have not demonstrated shared savings after 3 years, even though it supposedly considers savings over a 5-year period. Dr Kolodziej and Mr Okon comment that it is difficult for practices to demonstrate savings and increase income within this relatively short time frame.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More